The rationale for using apoA-I as a clinical marker of cardiovascular risk

81Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An inverse relationship between the concentration of high-density lipoprotein (HDL) cholesterol and the risk of developing cardiovascular is well established. There are several documented functions of HDLs that may contribute to a protective role of these lipoproteins. These include the ability of HDLs to promote the efflux of cholesterol from macrophages and foam cells in the artery wall and to anti-inflammatory/antioxidant properties of these lipoproteins. The fact that the main apolipoprotein of HDLs, apoA-I, plays a prominent role in each of these functions adds support to the view that apoA-I should be measured as a component of the assessment of cardiovascular risk in humans. © 2006 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Barter, P. J., & Rye, K. A. (2006). The rationale for using apoA-I as a clinical marker of cardiovascular risk. In Journal of Internal Medicine (Vol. 259, pp. 447–454). https://doi.org/10.1111/j.1365-2796.2006.01647.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free